As a homolog of NFE2L2, NFE2L3 has been proven to be related to multiple phenotypes of malignant tumors as well, including proliferation and epithelial-mesenchymal transition (EMT) (Bury et al., 2019; Ren et al., 2020). The gene discussed is NFE2L3; the disease is cancer.